ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
This review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. C...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2010-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849341465929449472 |
|---|---|
| author | M. G. Bubnova |
| author_facet | M. G. Bubnova |
| author_sort | M. G. Bubnova |
| collection | DOAJ |
| description | This review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. Clinical groups in need for aspirin therapy, as a part of primary or secondary prevention, are specified, based on the evidence from large clinical trials. The benefits and risks of aspirin therapy are discussed. |
| format | Article |
| id | doaj-art-acc89d36edad4b59a01bc8a35cf584b8 |
| institution | Kabale University |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2010-08-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-acc89d36edad4b59a01bc8a35cf584b82025-08-20T03:43:37Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202010-08-01041151211263ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASEM. G. Bubnova0ФГУ Государственный научно-исследовательский Центр профилактической медицины Росмедтехнологии, МоскваThis review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. Clinical groups in need for aspirin therapy, as a part of primary or secondary prevention, are specified, based on the evidence from large clinical trials. The benefits and risks of aspirin therapy are discussed.https://russjcardiol.elpub.ru/jour/article/view/1476atherothrombosiscoronary heart diseaseaspirinprevention |
| spellingShingle | M. G. Bubnova ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE Российский кардиологический журнал atherothrombosis coronary heart disease aspirin prevention |
| title | ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE |
| title_full | ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE |
| title_fullStr | ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE |
| title_full_unstemmed | ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE |
| title_short | ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE |
| title_sort | aspirin in the prevention of atherothrombosis and coronary heart disease |
| topic | atherothrombosis coronary heart disease aspirin prevention |
| url | https://russjcardiol.elpub.ru/jour/article/view/1476 |
| work_keys_str_mv | AT mgbubnova aspirininthepreventionofatherothrombosisandcoronaryheartdisease |